Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...

(Reuters) -Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine ...

Vaccine and biotech stocks plummeted after Peter Marks, a top regulator at the US Food and Drug Administration, resigned due ...

Biotech stocks plunge after Dr. Peter Marks resigns from FDA, citing disputes with RFK Jr. over vaccines and drug approvals.